Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Aldose Reductase Mediates NLRP3 Inflammasome-Initiated Innate Immune Response in Hyperglycemia-Induced Thp1 Monocytes and Male Mice.

Endocrinology | 2017

Despite recent studies that show oxidative stress-generated reactive oxygen species (ROS) regulate NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome-mediated innate immune response in various diabetic complications, the mechanism by which ROS activate innate immune response is not well understood. We have shown previously that aldose reductase (AR), besides reducing glucose, reduces lipid aldehydes and their glutathione conjugates and participates in various oxidative stress-induced inflammatory pathways. To understand the role of AR in ROS-induced innate immune response, we have investigated the mechanism(s) by which AR activates hyperglycemia-induced NLRP3 inflammsome-initiated innate immune response in Thp1 monocytes and in streptozotocin (STZ)-induced diabetic mice. In Thp1 monocytes, inhibition or ablation of AR prevented high-glucose-induced activation of NLRP3 inflammasome and caspase-1 and release of the innate immune cytokines interleukin (IL)-1β and IL-18. AR inhibition in Thp1 cells also prevented the high-glucose-induced generation of ROS, influx of Ca2+, efflux of K+, and activation of Lyn, Syk, and PI3K. Furthermore, the AR inhibitor fidarestat prevented the expression of NLRP inflammasome components in STZ-induced diabetic mouse heart and aorta, and also prevented the release of various cytokines in the serum. Collectively, our data suggest that AR regulates hyperglycemia-induced NLRP3 inflammasome-mediated innate immune response by altering the ROS/Lyn/Syk/PI3K/Ca2+/K+ signals.

Pubmed ID: 28938395 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Phospho-Syk (Tyr525/526) (C87C1) Rabbit mAb (antibody)

RRID:AB_2197222

This monoclonal targets Phospho-Syk (Tyr525/526)

View all literature mentions

Normal Rabbit IgG (antibody)

RRID:AB_1031062

This isotype control targets not applicable

View all literature mentions

Phospho-Lyn (Tyr507) Antibody (antibody)

RRID:AB_2138262

This polyclonal targets Phospho-Lyn (Tyr507)

View all literature mentions

Aldose Reductase (P-20) (antibody)

RRID:AB_667749

This polyclonal targets AKR1B1

View all literature mentions

ASC Antibody (N-15) (antibody)

RRID:AB_2174874

This polyclonal targets PYCARD

View all literature mentions

IL-18 (H-173) (antibody)

RRID:AB_1564060

This polyclonal targets IL-18 (H-173)

View all literature mentions

IL-1beta (H-153) (antibody)

RRID:AB_2124476

This polyclonal targets IL1B

View all literature mentions